C Difficile

9585 bookmarks
Newest
Clostridium Difficile Infections Pipeline Analysis 2024: FDA Approvals and Emerging Therapies by DelveInsight| Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Baxter International Inc., Sanof
Clostridium Difficile Infections Pipeline Analysis 2024: FDA Approvals and Emerging Therapies by DelveInsight| Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Baxter International Inc., Sanof
Las Vegas Nevada United States As per DelveInsight s assessment globally Clostridium Difficile Infections pipeline constitutes 20 key companies continuously working towards developing 22 Clostridium Difficile Infections treatment therapies analysis of Clinical Trials Therapies Mechanism of Action Route of Administration ...
·news.google.com·
Clostridium Difficile Infections Pipeline Analysis 2024: FDA Approvals and Emerging Therapies by DelveInsight| Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Baxter International Inc., Sanof
The impact of YabG mutations on C. difficile spore germination and processing of spore substrates - PubMed
The impact of YabG mutations on C. difficile spore germination and processing of spore substrates - PubMed
YabG is a sporulation-specific protease that is conserved among sporulating bacteria. C. difficile YabG processes cortex destined proteins preproSleC into proSleC and CspBA to CspB and CspA. YabG also affects synthesis of spore coat/exosporium proteins CotA and CdeM. In prior work that identi …
·pubmed.ncbi.nlm.nih.gov·
The impact of YabG mutations on C. difficile spore germination and processing of spore substrates - PubMed
Intestinal microbiota imbalance resulted by anti-Toxoplasma gondii immune responses aggravate gut and brain injury - PubMed
Intestinal microbiota imbalance resulted by anti-Toxoplasma gondii immune responses aggravate gut and brain injury - PubMed
Our study revealed that host immune responses against T. gondii infection severely disrupted the balance of gut microbiota, resulting in intestinal and brain damage. Lactobacillus spp. play a crucial role in immune regulation, and the metabolite ILA is a promising therapeutic compound for efficient …
·pubmed.ncbi.nlm.nih.gov·
Intestinal microbiota imbalance resulted by anti-Toxoplasma gondii immune responses aggravate gut and brain injury - PubMed
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
In contrast to the epidemiology 10 years earlier at our hospital when the epidemic restriction endonuclease analysis (REA) group strain BI accounted for 72% of Clostridioides difficile isolates recovered from first-episode C. difficile infection (CDI) cases, BI represented 19% of first …
·pubmed.ncbi.nlm.nih.gov·
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Clostridioides difficile causes a serious diarrheal disease and is a common healthcare-associated bacterial pathogen. Although it has a major impact on human health, the mechanistic details of C. difficile intestinal colonization remain undefined. C. difficile is highly sensitiv …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis - PubMed
Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis - PubMed
Clostridioides difficile infection (CDI) poses a significant health threat due to high recurrence rates. Antimicrobial agents are commonly used to manage CDI-related diarrhoea; however, by aggravating intestinal dysbiosis, antibiotics enable C. difficile spores germination and production of toxins, …
·pubmed.ncbi.nlm.nih.gov·
Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis - PubMed
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Clostridioides difficile causes a serious diarrheal disease and is a common healthcare-associated bacterial pathogen. Although it has a major impact on human health, the mechanistic details of C. difficile intestinal colonization remain undefined. C. difficile is highly sensitiv …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile superoxide reductase mitigates oxygen sensitivity - PubMed
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
In contrast to the epidemiology 10 years earlier at our hospital when the epidemic restriction endonuclease analysis (REA) group strain BI accounted for 72% of Clostridioides difficile isolates recovered from first-episode C. difficile infection (CDI) cases, BI represented 19% of first …
·pubmed.ncbi.nlm.nih.gov·
Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures - PubMed
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
This proof-of-concept study shows that specific modifications of FVT hold promise in addressing challenges related to donor variability and infection risks. Two strategies lead to treatments significantly limiting C. difficile colonization in mice, with solvent/detergent treatment and chemostat prop …
·pubmed.ncbi.nlm.nih.gov·
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
Molecular Clostridium Difficile Diagnostic Equipment Market Expected to Reach XX Billion by 2032 due to Rising Global Awareness of Infections
Molecular Clostridium Difficile Diagnostic Equipment Market Expected to Reach XX Billion by 2032 due to Rising Global Awareness of Infections
Dataintelo recently unveiled its latest report detailing the global Molecular Clostridium Difficile Diagnostic Equipment market which was valued at USD XX Billion in 2023 This exhaustively researched study projects that the market will go on to reach a striking USD ...
·news.google.com·
Molecular Clostridium Difficile Diagnostic Equipment Market Expected to Reach XX Billion by 2032 due to Rising Global Awareness of Infections
Immuron requests pre-IND meeting for IMM-529 with FDA filing
Immuron requests pre-IND meeting for IMM-529 with FDA filing
MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has filed a pre-IND (investigational new...
·news.google.com·
Immuron requests pre-IND meeting for IMM-529 with FDA filing
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
This proof-of-concept study shows that specific modifications of FVT hold promise in addressing challenges related to donor variability and infection risks. Two strategies lead to treatments significantly limiting C. difficile colonization in mice, with solvent/detergent treatment and chemostat prop …
·pubmed.ncbi.nlm.nih.gov·
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments - PubMed
#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin | 2 Minute Medicine
#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin | 2 Minute Medicine
Click here to read this study in CID. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
·news.google.com·
#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin | 2 Minute Medicine
Antibiotic resistance of enteropathogenic bacteria in a teaching hospital in North Khuzestan during a three-year period - PubMed
Antibiotic resistance of enteropathogenic bacteria in a teaching hospital in North Khuzestan during a three-year period - PubMed
Susceptibility to antibiotics was different among the isolates, which shows that the early identification of the infection agent and the selection of the correct antibiotic treatment are effective in improving the gastrointestinal infection and preventing the spread of the infection.
·pubmed.ncbi.nlm.nih.gov·
Antibiotic resistance of enteropathogenic bacteria in a teaching hospital in North Khuzestan during a three-year period - PubMed
Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice - PubMed
Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice - PubMed
Rationale: Currently, there are occasional reports of health problems caused by sleep deprivation (SD). However, to date, there remains a lack of in-depth research regarding the effects of SD on the growth and development of oocytes in females. The present work aimed to investigate whether SD …
·pubmed.ncbi.nlm.nih.gov·
Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice - PubMed
Frontiers | High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
Frontiers | High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
IntroductionClostridioides difficile is a neglected pathogen in many African countries as it is generally not regarded as one of the major contributors towar...
·news.google.com·
Frontiers | High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
Frontiers | Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
Frontiers | Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
IntroductionClostridioides difficile infection (CDI) is the main cause of nosocomial diarrhea in developed countries. A key challenge in CDI is the lack of o...
·news.google.com·
Frontiers | Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
Differences in enteric pathogens and intestinal microbiota between diarrheic weaned piglets and healthy penmates - PubMed
Differences in enteric pathogens and intestinal microbiota between diarrheic weaned piglets and healthy penmates - PubMed
Postweaning diarrhea (PWD) is a multifactorial disease caused by different aetiological agents, like viruses or bacteria and where the role of the microbiota remains unclear. The aim of this study was to assess differences between healthy and diarrheic weaned pigs concerning the prevalence of pathog …
·pubmed.ncbi.nlm.nih.gov·
Differences in enteric pathogens and intestinal microbiota between diarrheic weaned piglets and healthy penmates - PubMed
Potent and specific antibiotic combination therapy against Clostridioides difficile - PubMed
Potent and specific antibiotic combination therapy against Clostridioides difficile - PubMed
Keratinicyclins and keratinimicins are recently discovered glycopeptide antibiotics. Keratinimicins show broad-spectrum activity against Gram-positive bacteria, while keratinicyclins form a new chemotype by virtue of an unusual oxazolidinone moiety and exhibit specific antibiosis against Clostridioi …
·pubmed.ncbi.nlm.nih.gov·
Potent and specific antibiotic combination therapy against Clostridioides difficile - PubMed
Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile - PubMed
Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile - PubMed
The most frequent infection associated with hospital settings is Clostridioides difficile, which can cause fatal diarrhea and severe colitis, toxic megacolon, sepsis, and leaky gut. Those who have taken antibiotics for other illnesses that affect the gut's healthy microbiota are more suscepti …
·pubmed.ncbi.nlm.nih.gov·
Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile - PubMed
Frontiers | Global and Historical Distribution of Clostridioides difficile in the Human Diet (1981–2019): Systematic Review and Meta-Analysis of 21886 Samples Reveal Sources of Heterogeneity, High-Risk Foods, and Unexpected Higher Prevalence Toward the Tropic
Frontiers | Global and Historical Distribution of Clostridioides difficile in the Human Diet (1981–2019): Systematic Review and Meta-Analysis of 21886 Samples Reveal Sources of Heterogeneity, High-Risk Foods, and Unexpected Higher Prevalence Toward the Tropic
Clostridioides difficile (CD) is a spore-forming bacterium that causes life-threatening intestinal infections in humans. Although formerly regarded as exclus...
·news.google.com·
Frontiers | Global and Historical Distribution of Clostridioides difficile in the Human Diet (1981–2019): Systematic Review and Meta-Analysis of 21886 Samples Reveal Sources of Heterogeneity, High-Risk Foods, and Unexpected Higher Prevalence Toward the Tropic